A. McLaren

P. Khauka1
A. Burke1
P. Nkurunziza1
1P. Khauka
1A. Burke
1P. Nkurunziza
1B. Gazzard
Learn More
In a randomized comparison of nevirapine or abacavir with zidovudine plus lamivudine, routine viral load monitoring was not performed, yet 27% of individuals with viral failure at week 48 experienced resuppression by week 96 without switching. This supports World Health Organization recommendations that suspected viral failure should trigger adherence(More)
  • 1